These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11189839)

  • 21. Gamma probe-directed lymphatic mapping and sentinel lymphadenectomy in primary melanoma: Reliability of the procedure and analysis of failures after long-term follow-up.
    Jacobs IA; Chevinsky AH; Swayne LC; Magidson JG; Britto EJ; Smith TJ
    J Surg Oncol; 2001 Jul; 77(3):157-64. PubMed ID: 11455551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the sentinel lymph node in patients with malignant melanoma: what are the reasons for mistakes?
    Vidal-Sicart S; Pons F; Puig S; Ortega M; Vilalta A; Martín F; Rull R; Palou JM; Castel T
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):362-6. PubMed ID: 12634963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphatic drainage patterns of head and neck cutaneous melanoma observed on lymphoscintigraphy and sentinel lymph node biopsy.
    Lin D; Franc BL; Kashani-Sabet M; Singer MI
    Head Neck; 2006 Mar; 28(3):249-55. PubMed ID: 16470744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical management of aberrant sentinel lymph node drainage in cutaneous melanoma.
    Lieber KA; Standiford SB; Kuvshinoff BW; Ota DM
    Surgery; 1998 Oct; 124(4):757-61; discussion 761-2. PubMed ID: 9780998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphoscintigraphy in clinical routine practice: reproducibility and accuracy in melanoma patients with a long-term follow-up.
    Vitali GC; Trifirò G; Zonta M; Pennacchioli E; Santoro L; Travaini LL; Barberis M; Testori A
    Eur J Surg Oncol; 2014 Jan; 40(1):55-60. PubMed ID: 24094681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Contribution of nuclear medicine to lymphatic mapping and sentinel node identification in oncology].
    Valdés Olmos RA; Jansen L; Muller SH; Hoefnagel CA; Nieweg O
    Rev Esp Med Nucl; 1999; 18(2):111-21. PubMed ID: 10352326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel lymph node mapping in the management of high risk malignant melanoma.
    Donckier V; Vereecken P; Blocklet D; Laporte M; Velu T; Heenen M; Van Geertruyden J
    Acta Chir Belg; 1999 Dec; 99(6):295-8. PubMed ID: 10674132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Selective regional lymphadenectomy in malignant melanoma using a gamma probe].
    Rettenbacher L; Koller J; Gmeiner D; Kässmann H; Galvan G
    Acta Med Austriaca; 1997; 24(2):79-80. PubMed ID: 9273811
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interval sentinel lymph nodes in patients with cutaneous melanoma: a single-institution study in Japan.
    Matsumoto T; Shibata S; Yasue S; Sakakibara A; Yokota K; Sawada M; Kono M; Kato K; Shimoyama Y; Tomita Y
    J Dermatol; 2010 Jul; 37(7):629-34. PubMed ID: 20629829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reproducibility of lymphoscintigraphy in cutaneous melanoma: can we accurately detect the sentinel lymph node by expanding the tracer injection distance from the tumor site?
    Rettenbacher L; Koller J; Kässmann H; Holzmannhofer J; Rettenbacher T; Galvan G
    J Nucl Med; 2001 Mar; 42(3):424-9. PubMed ID: 11337518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eight Years' Experience of Sentinel Lymph Node Biopsy in Melanoma Using Lymphoscintigraphy and Gamma Probe Detection After Radiocolloid Mapping.
    Pham Dang N; Cassier S; Mulliez A; Mansard S; DʼIncan M; Barthélémy I
    Dermatol Surg; 2017 Feb; 43(2):287-292. PubMed ID: 27893540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphatic mapping and sentinel node biopsy in patients with malignant melanoma.
    Reintgen D; Rapaport D; Tanabe KK; Ross M
    J Fla Med Assoc; 1997 Mar; 84(3):188-93. PubMed ID: 9143171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sentinel lymph node detection with lymphoscintigraphy and intraoperative probe in malignant melanoma patients].
    Vidal-Sicart S; Piulachs J; Pons F; Castel T; Palou J; Herranz R
    Med Clin (Barc); 1999 May; 112(18):681-4. PubMed ID: 10374197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The definition of the sentinel lymph node in melanoma based on radioactive counts.
    Carlson GW; Murray DR; Thourani V; Hestley A; Cohen C
    Ann Surg Oncol; 2002 Nov; 9(9):929-33. PubMed ID: 12417518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Axillary sentinel lymph-node biopsy: gamma probe assisted sonographic localisation.
    Hollerweger A; Macheiner P; Hübner E; Gritzmann N
    Ultraschall Med; 2006 Feb; 27(1):34-9. PubMed ID: 16470477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive role of imaging in sentinel lymph node dissection for melanoma.
    Ho AM; Avery R; Krupinski EA; Warneke J; Kuo PH
    Lymphology; 2014 Sep; 47(3):134-41. PubMed ID: 25420306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy of the intra-operative radioguided localization of the sentinel lymph node (SLN) 24 hours after lymphoscintigraphy in patients with malignant melanoma.
    Kropp J; Stein A; Hackert I; Sebastian G; Meurer M; Grüning T; Liepe K; Pinkert J; Franke WG
    Nuklearmedizin; 2001 Jun; 40(3):86-90. PubMed ID: 11475078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temporary shielding of hot spots in the drainage areas of cutaneous melanoma improves accuracy of lymphoscintigraphic sentinel lymph node diagnostics.
    Maza S; Valencia R; Geworski L; Zander A; Dräger E; Winter H; Sterry W; Munz DL
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1399-402. PubMed ID: 12271426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The predictive value of the sentinel lymph node in malignant melanomas.
    Bachter D; Michl C; Büchels H; Vogt H; Balda BR
    Recent Results Cancer Res; 2001; 158():129-36. PubMed ID: 11092040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of fast lymphatic drainage on metastatic spread in cutaneous malignant melanoma: a prospective feasibility study.
    Maza S; Valencia R; Geworski L; Sandrock D; Zander A; Audring H; Dräger E; Winter H; Sterry W; Munz DL
    Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):538-44. PubMed ID: 12582814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.